HEALTH

CRN signs six new members, including Reckitt Benckiser

BY Michael Johnsen

WASHINGTON — The Council for Responsible Nutrition on Monday named six new members, including Aurora Algae, Nature’s Sources, Reckitt Benckiser, Sirio Pharma, Watson and international member JJ Health.    

British conglomerate Reckitt Benckiser recently acquired Schiff Nutrition, marking the entry of a new major CPG player into the dietary supplement space. Reckitt Benckiser now markets several supplement brands including Digestive Advantage, MegaRed and Schiff Move Free. 

Aurora Algae is a producer of sustainable algae-based products for the pharmaceutical, nutrition, aquaculture and fuels markets. Nature’s Sources manufactures and distributes digestive enzymes and other dietary supplements. Sirio Pharma is a contract manufacturer in compliance. Watson helps develop products and ingredient systems for the food and dietary supplement industries, including specialized micronutrient premixes. And JJ Health is an online distributor of dietary supplements in the Chinese market.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

CRN issues marketing guidelines for caffeine-containing dietary supplement products

BY Michael Johnsen

WASHINGTON — The Council for Responsible Nutrition last week issued recommended guidelines for caffeine-containing dietary supplement products, expanding its self-regulatory initiatives that encourage best practices within the supplement industry. 

“These recommendations go beyond what is required by law, but our member companies, along with the conventional beverage industry, recognize that consumers would benefit by having information that lets them know how much caffeine is in the products they choose to take,” stated Steve Mister, president and CEO, CRN. “This is one example of how responsible companies in our industry are taking proactive steps to educate consumers so they can make informed decisions about caffeine-containing supplements, and we trust consumers will be mindful of the amounts of caffeine they are getting from all sources.” 

According to a DSN report posted last month, a group of doctors and public health professors petitioned the Food and Drug Administration to place stronger regulations on energy drinks out of concerns of high caffeine consumption. In a letter the group noted that energy drinks are projected to reach $19.7 billion in sales this year and that, according to an FDA-commissioned study from 2010, 65% of the people consuming them are ages 13 years to 35 years. 

The new CRN guidelines focus on five core areas: disclosure of total caffeine content from both added and naturally occurring sources of caffeine; label advisories for conditions of use; serving size and daily intake recommendations; restraints against marketing in combination with alcohol; and implementation for product labels.

The guidelines call on manufacturers to disclose on the product label the total amount of caffeine, from both natural sources like green tea extract, coffee bean extract, guarana or yerba mate, as well as added caffeine. In addition to the recommendation for label disclosure of total caffeine content, the guidelines recommend that products with a total caffeine content of more than 100 mg per serving include label advisories for children, those sensitive to caffeine, pregnant or nursing women, and those with a medical condition or taking medication. 

“The guidelines are not intended to be rigid or compulsory for the industry, but rather to give firms a model of how to communicate with their consumers about these products," Mister noted. "Companies looking to do the right thing can adopt these flexible recommendations for developing their own product labels.” 

The guidelines are effective April 1, 2013, with a recommended implementation time of 12 months, allowing companies sufficient time to comply with the guidelines for new product labels put into the market.


Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

NAD recommends Matrixx discontinue preventive claims for Zicam cold remedies

BY Michael Johnsen

NEW YORK — The National Advertising Division on Friday recommended that Matrixx Initiatives discontinue advertising claims that suggest its homeopathic Zicam Cold Remedy products prevent users from catching a cold.

Claims at issue were featured in an advertising campaign that depicted a “Cold Monster” and encouraged treatment with Zicam products at the “pre-cold” stage.

Claims included “The Pre-Cold Medicine"; “Take Zicam Now And Go From Pre-Cold To No Cold, Faster"; and “clinically proven [to reduce the duration of a cold].”

Given the context in which they appeared, NAD found that the claims “Pre-Cold Medicine” and “Go from Pre-Cold to No Cold Faster” were unlikely to convey to consumers the message Zicam Cold Remedy products provide a prophylactic benefit. NAD also recommended that all iterations of the advertiser’s “clinically proven [to reduce the duration of a cold]” claims — in TV, print, Internet and other advertising media — clearly and conspicuously disclose that the claim applies solely to its Zicam Rapid Melts, Chewables and Oral mist products.

Matrixx, in its advertiser’s statement, said the company acknowledges NAD’s concerns and has taken steps to addresses NAD’s recommendations.

NAD is an investigative unit of the advertising industry system of self-regulation and is administered by the Council of Better Business Bureaus. ProPhase Labs had initiated the marketing challenge.

NAD is an investigative unit of the advertising industry system of self-regulation and is administered by the Council of Better Business Bureaus. ProPhase Labs had initiated the marketing challenge.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES